How big is the digital biomarkers market?

The global digital biomarkers market size was estimated at USD 3.42 billion in 2023 and is expected to reach USD 4.09 billion in 2024.

What is the digital biomarkers market growth?

The global digital biomarkers market is expected to grow at a compound annual growth rate of 22.7% from 2024 to 2030 to reach USD 13.97 billion by 2030.

Which segment accounted for the largest digital biomarkers market share?

North America dominated the market and accounted for a revenue share of over 58.45% in 2023, owing to the strong presence of leading market players, significant product launches, increase in investments in R&D growing approval of smart devices, and improved awareness of digital biomarker effectiveness in the region. Furthermore, the increasing number of initiatives to promote healthcare IT and the presence of healthcare programs are some of the primary reasons for this region to anticipate market growth.

Who are the key players in the digital biomarkers market?

Some key players operating in the digital biomarkers market include ActiGraph LLC; AliveCor Inc.; Koneksa; Altoida Inc.; Amgen Inc.; Biogen Inc.; Empatica Inc.; VivoSense; IXICO plc; Adherium Limited; Neurotrack Technologies, Inc.; Aural Analytic; Huma; Sonde Health, Inc.; Clario; Imagine AI; Brainomix; Kinsa Inc.; Feel Therapeutics; ResApp (Pfizer)

What are the factors driving the digital biomarkers market?

Key factors that are driving the market growth include an increase in the usage of health-related mobile applications and connected digital devices, rising usage of smartphones and the emergence of new wearables, and expanding therapeutic area applications across the world.